Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Chiurchiù V[au]:

The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases. Chiurchiù V et al. Prog Neurobiol. (2018)

TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Marrone MC et al. Nat Commun. (2017)

Endocannabinoids and Immunity. Chiurchiù V et al. Cannabis Cannabinoid Res. (2016)

Search results

Items: 42

1.

Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons.

Gentile A, De Vito F, Fresegna D, Rizzo FR, Bullitta S, Guadalupi L, Vanni V, Buttari F, Stampanoni Bassi M, Leuti A, Chiurchiù V, Marfia GA, Mandolesi G, Centonze D, Musella A.

Neuropathol Appl Neurobiol. 2019 May 24. doi: 10.1111/nan.12569. [Epub ahead of print]

PMID:
31125471
2.

Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes.

Chiurchiù V, Leuti A, Saracini S, Fontana D, Finamore P, Giua R, Padovini L, Incalzi RA, Maccarrone M.

FASEB J. 2019 Jan;33(1):909-916. doi: 10.1096/fj.201801017R. Epub 2018 Jul 27.

PMID:
30052486
3.

From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System.

Lo Iacono L, Catale C, Martini A, Valzania A, Viscomi MT, Chiurchiù V, Guatteo E, Bussone S, Perrone F, Di Sabato P, Aricò E, D'Argenio A, Troisi A, Mercuri NB, Maccarrone M, Puglisi-Allegra S, Casella P, Carola V.

Biol Psychiatry. 2018 Dec 15;84(12):905-916. doi: 10.1016/j.biopsych.2018.05.022. Epub 2018 Jun 11.

PMID:
30029767
4.

Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes.

Chiurchiù V, Leuti A, Smoum R, Mechoulam R, Maccarrone M.

FASEB J. 2018 Oct;32(10):5716-5723. doi: 10.1096/fj.201800107R. Epub 2018 Jun 7.

PMID:
29879374
5.

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.

Chiurchiù V, Leuti A, Maccarrone M.

Front Immunol. 2018 Jan 29;9:38. doi: 10.3389/fimmu.2018.00038. eCollection 2018. Review.

6.

Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX/FPR2 Receptor-Regulated MicroRNAs.

Bisicchia E, Sasso V, Catanzaro G, Leuti A, Besharat ZM, Chiacchiarini M, Molinari M, Ferretti E, Viscomi MT, Chiurchiù V.

Mol Neurobiol. 2018 Aug;55(8):6894-6905. doi: 10.1007/s12035-018-0889-z. Epub 2018 Jan 22.

PMID:
29357041
7.

The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases.

Chiurchiù V, van der Stelt M, Centonze D, Maccarrone M.

Prog Neurobiol. 2018 Jan;160:82-100. doi: 10.1016/j.pneurobio.2017.10.007. Epub 2017 Oct 31. Review.

8.

TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice.

Marrone MC, Morabito A, Giustizieri M, Chiurchiù V, Leuti A, Mattioli M, Marinelli S, Riganti L, Lombardi M, Murana E, Totaro A, Piomelli D, Ragozzino D, Oddi S, Maccarrone M, Verderio C, Marinelli S.

Nat Commun. 2017 May 10;8:15292. doi: 10.1038/ncomms15292.

9.

Impairment of systemic DHA synthesis affects macrophage plasticity and polarization: implications for DHA supplementation during inflammation.

Talamonti E, Pauter AM, Asadi A, Fischer AW, Chiurchiù V, Jacobsson A.

Cell Mol Life Sci. 2017 Aug;74(15):2815-2826. doi: 10.1007/s00018-017-2498-9. Epub 2017 Mar 15.

10.

Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients.

Tiribuzi R, Crispoltoni L, Chiurchiù V, Casella A, Montecchiani C, Del Pino AM, Maccarrone M, Palmerini CA, Caltagirone C, Kawarai T, Orlacchio A, Orlacchio A.

J Neurol Sci. 2017 Jan 15;372:408-412. doi: 10.1016/j.jns.2016.11.004. Epub 2016 Nov 6.

PMID:
27865556
11.

Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors.

Chiurchiù V, Leuti A, Cencioni MT, Albanese M, De Bardi M, Bisogno T, Centonze D, Battistini L, Maccarrone M.

Pharmacol Res. 2016 Nov;113(Pt A):313-319. doi: 10.1016/j.phrs.2016.09.003. Epub 2016 Sep 8.

PMID:
27616551
12.

Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.

Chiurchiù V, Rapino C, Talamonti E, Leuti A, Lanuti M, Gueniche A, Jourdain R, Breton L, Maccarrone M.

J Immunol. 2016 Nov 1;197(9):3545-3553. Epub 2016 Sep 30.

13.

Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.

Chiurchiù V, Leuti A, Dalli J, Jacobsson A, Battistini L, Maccarrone M, Serhan CN.

Sci Transl Med. 2016 Aug 24;8(353):353ra111. doi: 10.1126/scitranslmed.aaf7483.

14.

Bioactive lipids as modulators of immunity, inflammation and emotions.

Chiurchiù V, Maccarrone M.

Curr Opin Pharmacol. 2016 Aug;29:54-62. doi: 10.1016/j.coph.2016.06.005. Epub 2016 Jun 30. Review.

PMID:
27372887
15.

Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.

Chiurchiù V, Orlacchio A, Maccarrone M.

Oxid Med Cell Longev. 2016;2016:7909380. doi: 10.1155/2016/7909380. Epub 2015 Dec 31. Review.

16.

Endocannabinoids and Immunity.

Chiurchiù V.

Cannabis Cannabinoid Res. 2016 Feb 1;1(1):59-66. doi: 10.1089/can.2016.0002. eCollection 2016. Review.

17.

Correction: activation of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducing cholesterol efflux from human macrophages.

Lanuti M, Talamonti E, Maccarrone M, Chiurchiù V.

PLoS One. 2015 Jun 25;10(6):e0131850. doi: 10.1371/journal.pone.0131850. eCollection 2015. No abstract available.

18.

Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.

Lanuti M, Talamonti E, Maccarrone M, Chiurchiù V.

PLoS One. 2015 May 13;10(5):e0126839. doi: 10.1371/journal.pone.0126839. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0131850.

19.

A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.

Ribeiro A, Pontis S, Mengatto L, Armirotti A, Chiurchiù V, Capurro V, Fiasella A, Nuzzi A, Romeo E, Moreno-Sanz G, Maccarrone M, Reggiani A, Tarzia G, Mor M, Bertozzi F, Bandiera T, Piomelli D.

ACS Chem Biol. 2015 Aug 21;10(8):1838-46. doi: 10.1021/acschembio.5b00114. Epub 2015 Apr 15.

20.

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.

Chiurchiù V, Leuti A, Maccarrone M.

J Neuroimmune Pharmacol. 2015 Jun;10(2):268-80. doi: 10.1007/s11481-015-9584-2. Epub 2015 Jan 20. Review.

PMID:
25601726
21.

Endocannabinoid signalling in innate and adaptive immunity.

Chiurchiù V, Battistini L, Maccarrone M.

Immunology. 2015 Mar;144(3):352-364. doi: 10.1111/imm.12441. Review.

22.

Novel targets in multiple sclerosis: to oxidative stress and beyond.

Chiurchiù V.

Curr Top Med Chem. 2014;14(22):2590-9. Review.

PMID:
25478879
23.

Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors.

Gasperi V, Evangelista D, Oddi S, Florenzano F, Chiurchiù V, Avigliano L, Catani MV, Maccarrone M.

Life Sci. 2015 Oct 1;138:41-51. doi: 10.1016/j.lfs.2014.09.031. Epub 2014 Oct 15.

PMID:
25445433
24.

2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts.

Gasperi V, Avigliano L, Evangelista D, Oddi S, Chiurchiù V, Lanuti M, Maccarrone M, Valeria Catani M.

Cell Cycle. 2014;13(24):3938-47. doi: 10.4161/15384101.2014.982941.

25.

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.

Chiurchiù V, Lanuti M, De Bardi M, Battistini L, Maccarrone M.

Int Immunol. 2015 Mar;27(3):153-60. doi: 10.1093/intimm/dxu097. Epub 2014 Oct 25.

PMID:
25344934
26.

Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.

Latini L, Bisicchia E, Sasso V, Chiurchiù V, Cavallucci V, Molinari M, Maccarrone M, Viscomi MT.

Cell Death Dis. 2014 Sep 4;5:e1404. doi: 10.1038/cddis.2014.364.

27.

2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors.

Gasperi V, Evangelista D, Chiurchiù V, Florenzano F, Savini I, Oddi S, Avigliano L, Catani MV, Maccarrone M.

Int J Biochem Cell Biol. 2014 Jun;51:79-88. doi: 10.1016/j.biocel.2014.03.028. Epub 2014 Apr 8.

PMID:
24721209
28.

Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor.

Chiurchiù V, Lanuti M, Catanzaro G, Fezza F, Rapino C, Maccarrone M.

Atherosclerosis. 2014 Mar;233(1):55-63. doi: 10.1016/j.atherosclerosis.2013.12.042. Epub 2014 Jan 8.

PMID:
24529123
29.

The role of reticulons in neurodegenerative diseases.

Chiurchiù V, Maccarrone M, Orlacchio A.

Neuromolecular Med. 2014 Mar;16(1):3-15. doi: 10.1007/s12017-013-8271-9. Epub 2013 Nov 12. Review.

30.

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M.

Prog Lipid Res. 2013 Oct;52(4):633-50. doi: 10.1016/j.plipres.2013.05.004. Epub 2013 Sep 25. Review.

PMID:
24076098
31.

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.

Chiurchiù V, Cencioni MT, Bisicchia E, De Bardi M, Gasperini C, Borsellino G, Centonze D, Battistini L, Maccarrone M.

Ann Neurol. 2013 May;73(5):626-36. doi: 10.1002/ana.23875. Epub 2013 Apr 17.

PMID:
23447381
32.

Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two.

Bisicchia E, Chiurchiù V, Viscomi MT, Latini L, Fezza F, Battistini L, Maccarrone M, Molinari M.

Cell Mol Life Sci. 2013 Jun;70(12):2191-204. doi: 10.1007/s00018-012-1253-5. Epub 2013 Jan 8.

PMID:
23296125
33.

Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1.

Chiurchiù V, Maccarrone M, Orlacchio A.

Expert Opin Ther Pat. 2012 Feb;22(2):181-4. doi: 10.1517/13543776.2012.655269. Epub 2012 Jan 18.

PMID:
22251081
34.

Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling.

Oddi S, Dainese E, Sandiford S, Fezza F, Lanuti M, Chiurchiù V, Totaro A, Catanzaro G, Barcaroli D, De Laurenzi V, Centonze D, Mukhopadhyay S, Selent J, Howlett AC, Maccarrone M.

Br J Pharmacol. 2012 Apr;165(8):2635-51. doi: 10.1111/j.1476-5381.2011.01658.x.

35.

Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities.

Chiurchiù V, Maccarrone M.

Antioxid Redox Signal. 2011 Nov 1;15(9):2605-41. doi: 10.1089/ars.2010.3547. Epub 2011 Jun 6. Review.

PMID:
21391902
36.

Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages.

Chiurchiù V, Izzi V, D'Aquilio F, Vismara D, Carotenuto F, Catanzaro G, Maccarrone M.

Peptides. 2011 Jan;32(1):80-5. doi: 10.1016/j.peptides.2010.09.024. Epub 2010 Oct 13.

PMID:
20932867
37.

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

Cencioni MT, Chiurchiù V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M.

PLoS One. 2010 Jan 14;5(1):e8688. doi: 10.1371/journal.pone.0008688.

38.

Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages.

Izzi V, Chiurchiù V, D'Aquilio F, Palumbo C, Tresoldi I, Modesti A, Baldini PM.

Int J Oncol. 2009 Feb;34(2):543-50.

PMID:
19148491
39.

Endomorphin-1 inhibits the activation and the development of a hyporesponsive-like phenotype in lipopolysaccharide- stimulated THP-1 monocytes.

Izzi V, Chiurchiù V, D'Aquilio F, Martino A, Tresoldi I, Modesti A, Baldini PM.

Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):833-43.

PMID:
19144269
40.

Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages.

Chiurchiù V, Izzi V, D'Aquilio F, Carotenuto F, Di Nardo P, Baldini PM.

Regul Pept. 2008 Jun 5;148(1-3):26-32. doi: 10.1016/j.regpep.2008.02.009. Epub 2008 Mar 10.

PMID:
18410972
41.

Activatory properties of lysophosphatidic acid on human THP-1 cells.

D'Aquilio F, Procaccini M, Izzi V, Chiurchiu' V, Giambra V, Carotenuto F, Di Nardo P, Baldini PM.

Inflammation. 2007 Oct;30(5):167-77.

PMID:
17594136
42.

Activatory properties of lysophosphatidic acid on human THP-1 cells.

D'Aquilio F, Procaccini M, Izzi V, Chiurchiu' V, Giambra V, Carotenuto F, Di Nardo P, Baldini PM.

Inflammation. 2005 Dec;29(4-6):129-40. Epub 2006 Nov 7.

PMID:
17089191

Supplemental Content

Loading ...
Support Center